and could be even better when they combine it with folfirinox study.
not sure if it’s just me but this company seems to fly under the radar a bit. Looked at verastem website and they’ve got a good investigator sponsored trial programme, about half their current trials are IST. It’s a great way to seed your assets with clinicians , raise profile, get future investigators on board at very low cost (often drug cost only)
Ann: AACR Conference Presentation, page-5
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
-0.005(3.33%) |
Mkt cap ! $39.84M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 15.5¢ | 14.5¢ | $47.81K | 319.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 161129 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| ATX (ASX) Chart |